Explainable illicit drug abuse prediction using hematological differences.

Journal: Scientific reports
Published Date:

Abstract

This study aimed to develop a reliable and explainable predictive model for illicit drug use (IDU). The model uses a machine learning (ML) algorithm to predict IDU using hematological differences between illicit drug users (IDUr) and non-users (n-IDUr). A total of 286 IDUr and 302 n-IDUr were included in this study. By comparing the IDU prediction performance of eight ML models, an explainable LGB model with 13 features was established, which could accurately predict IDU in both internal (area under the curve [AUC] = 0.925) and external (AUC = 0.915) validation sets. Using SHapley Additive exPlanations (SHAP) to explain our prediction model, we found that chloride (Cl), β-hydroxybutyrate (BHB), and anion gap (AG) had a strong influence on the results predicted. Many of the features used for model training are interrelated, serving as important indicators of kidney, liver, and thyroid function in hematological examinations. Combining these manifestations can enable doctors to perform preliminary screening for IDU while conducting corresponding organ examinations in ordinary patients, which has a profound importance in clinical practice.

Authors

  • Aijun Chen
    College of Metrology Measurement and Instrument, China Jiliang University, Hangzhou, 310018, China.
  • Yinchu Shen
    College of Metrology Measurement and Instrument, China Jiliang University, Hangzhou, 310018, China.
  • Yu Xu
    Panzhihua Central Hospital, Panzhihua, Sichuan, China.
  • Jinhui Cai
    Department of Radiology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
  • Bo Ye
    Department of Thoracic Surgery, Thoracic Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200030, China.
  • Jiaxue Sun
    The First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, 650500, China.
  • Jinze Du
    Department of Electrical Engineering, University of Southern California, Los Angeles, CA 90089, USA.
  • Deshenyue Kong
    The First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, 650500, China.